Search by Drug Name or NDC

    NDC 55111-0131-60 Ranitidine 75 mg/1 Details

    Ranitidine 75 mg/1

    Ranitidine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is RANITIDINE HYDROCHLORIDE.

    Product Information

    NDC 55111-0131
    Product ID 55111-131_654a9ddb-f441-a17a-f8ae-633148d041c8
    Associated GPIs 49200020100303
    GCN Sequence Number 023441
    GCN Sequence Number Description ranitidine HCl TABLET 75 MG ORAL
    HIC3 Z2D
    HIC3 Description HISTAMINE H2-RECEPTOR INHIBITORS
    GCN 10202
    HICL Sequence Number 004520
    HICL Sequence Number Description RANITIDINE HCL
    Brand/Generic Generic
    Proprietary Name Ranitidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ranitidine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name RANITIDINE HYDROCHLORIDE
    Labeler Name Dr. Reddy's Laboratories Limited
    Pharmaceutical Class Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075294
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0131-60 (55111013160)

    NDC Package Code 55111-131-60
    Billing NDC 55111013160
    Package 1 BOTTLE in 1 CARTON (55111-131-60) / 60 TABLET in 1 BOTTLE
    Marketing Start Date 2000-03-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 12a38e29-130c-6d41-1753-acccb0b41efe Details

    Revised: 5/2019